Keensight invests in B2B healthcare service companies (diagnostics, medtechs, software, CROs, CDMOs, prosthetics, etc.) whose offerings are essential to the smooth running of the medical industry.
Keensight is one of the most successful growth funds in France and Europe, with a particular focus on healthcare software and technology. As such, we are delighted to benefit from their expertise and to indirectly support companies with a strong impact on public health.
Copyright © 2026 AURæ
